PSMA6 and Recurrent lower respiratory tract infections: To our knowledge, Koenecke et al. (2021), along with their companion papers Thomsen et al. (2021) and Rose et al. (2021), are the only existing epidemiological studies exploring the potential association between alpha-1 blockers use and disease progression induced by lower respiratory tract infection.